NR5A1 and cancer: The resultant CCM/IR780@Arg/ELP/Rapa nanomicelles efficiently targeted cancer tissues and utilized a membrane fusion mechanism to anchor IR780 to cancer cell membranes while releasing L-Arg and ELP/Rapa cores into the cytoplasm.